Related Experiment Video
Updated: Apr 28, 2026
07:16
Biochemical Titration of Glycogen In vitro
Published on: November 25, 2013
27.9K
Glycogen storage disease in adults
G M Talente1, R A Coleman, C Alter
1University of North Carolina at Chapel Hill.
Annals of Internal Medicine
|February 1, 1994
Summary
Adults with glycogen storage disease (GSD) types Ia, Ib, and III experience various complications. Early treatment of hyperuricemia and pyelonephritis in GSD-Ia may prevent kidney damage, while GSD-III requires further research for myopathy prevention.
Area of Science:
- Metabolic disorders
- Genetics
- Endocrinology
Background:
- Glycogen storage diseases (GSD) are inherited metabolic disorders affecting glycogen metabolism.
- GSD types Ia, Ib, and III represent distinct enzymatic deficiencies with varying clinical manifestations.
- Complications in adult GSD patients can significantly impact quality of life and long-term health outcomes.
Observation:
- Adult patients with GSD-Ia frequently exhibit short stature, hepatomegaly, hepatic adenomas, anemia, kidney calcifications, osteopenia, and abnormal lipid profiles.
- GSD-Ib is characterized by severe recurrent bacterial infections and gingivitis.
- GSD-III patients often present with elevated creatinine kinase activity, myopathy, and cardiomyopathy.
Findings:
- Hyperuricemia and pyelonephritis in GSD-Ia are treatable conditions that can prevent nephrocalcinosis and further renal damage.
- Granulocyte-colony-stimulating factor (G-CSF) shows potential in preventing bacterial infections in GSD-Ib.
- Preventive strategies for myopathy and cardiomyopathy in GSD-III require further investigation.
Implications:
- Proactive management of specific complications in GSD types Ia, Ib, and III is crucial for improving patient outcomes.
- Further research is needed to establish preventive measures for GSD-III related myopathy and cardiomyopathy.
- Despite medical challenges, most adult GSD patients achieve significant educational attainment and maintain employment or schooling.
Related Concept Videos
01:22Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
01:27Glucose Transporters
15.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
01:20Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K